Neurol. praxi, 2012; 13(Suppl.E)

Painful and focal diabetic neuropathy

prof.MUDr.Zdeněk Ambler, DrSc.
Neurologická klinika LF UK a FN Plzeň

Painful diabetic neuropathy is common and is associated with significant reduction in quality of life. A distal and symmetric peripheral

neuropathy is the most frequent form, and small fiber damage is thought to result in painful symptoms. The much less common though

well recognized are acute painful and atypical neuropathies. A typical painful neuropathy develops on a background of long-standing

chronic hyperglycemia, associated metabolic derangements, and cardiovascular risk factors in a patient with a chronic, symmetrical,

length-dependent sensorimotor polyneuropathy. Atypical forms are different in several features. They can have an acute or subacute

onset and a monophasic or relapsing course that may develop at any time during a patient’s diabetes mellitus. These are not closely

associated with chronic hyperglycemia or the microvessel abnormalities. Pain may occur in both focal and multifocal forms of diabetic

neuropathy.

Keywords: neuropathic pain, typical and atypical forms of painful neuropathy, focal, multifocal neuropathies

Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambler Z. Painful and focal diabetic neuropathy. Neurol. praxi. 2012;13(Suppl.E):.
Download citation

References

  1. Abbott CA, Malik RA, Van Ross ERE, Kulkarni J, Boulton AJM. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011; 34: 2220-2224. Go to original source... Go to PubMed...
  2. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D. Evidence-based guideline: Treatment of painful diabetic neuropathy. Neurology 2011; 76: 1758-1765 (Muscle Nerve 2011; 6: 910-917). Go to original source... Go to PubMed...
  3. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 2012; 11: 521-534. Go to original source... Go to PubMed...
  4. Dabby R, Sadeh M, Lampl Y, Gilad R, Watemberg N. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomed Pharmacother 2009; 63: 707-709. Go to original source... Go to PubMed...
  5. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011; 27: 620-628. Go to original source... Go to PubMed...
  6. Ehler E. Neuropatická bolest u diabetické neuropatie. Neurol. praxi 2010; 11: 107-111.
  7. Gemignani F. Acute painful diabetic neuropathy induced by strict glycemic control (insulin neuritis): The old enigma is still unsolved. Biomed Pharmacother 2009; 63: 249-250. Go to original source... Go to PubMed...
  8. Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 2010; 67: 534-541. Go to original source... Go to PubMed...
  9. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003; 27: 465-470. Go to original source... Go to PubMed...
  10. Hartemann A, Attal N. Bouhassira D, Dumont I, Gin H, Jeanne S, Said G, Richard JL. Painful diabetic neuropathy: Diagnosis and management. Diabetes Metab 2011; 37: 377-388. Go to original source... Go to PubMed...
  11. Chi? A, Plano F, Calvo A, Leone M, Mutani R, Cocito D. Piemonte and Valle D'Aosta Registry for CIDP (PARCIDP). Comorbidity between CIDP and diabetes mellitus: only a matter of chance? Eur J Neurol 2009; 16: 752-754. Go to original source... Go to PubMed...
  12. Laughlin RS, Dyck PJ, Melton LJ III, Leibson C, Ransom J, Dyck PJB. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 2009; 73: 39-45. Go to original source... Go to PubMed...
  13. Malik RA, Veves A, Tesfaye S, Smith G, Cameron N, Zochodne D, Lauria G. on behalf of the Toronto consensus panel on diabetic neuropathy. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev 2011; 27: 678-684. Go to original source... Go to PubMed...
  14. Mondelli M, Rossi S, Romano C. Body mass index in meralgia paresthetica: a case-control study. Acta Neurol Scand 2007; 116: 118-123. Go to original source... Go to PubMed...
  15. Moravcová E, Bednařík J. Diabetická neuropatie. Neurol. praxi 2006; 2: 99-103.
  16. Parisi TJ, Mandrekar J, Dyck PJ, Klein CJ. Meralgia paresthetica: relation to obesity, advanced age, and diabetes mellitus. Neurology 2011; 77: 1538-1542. Go to original source... Go to PubMed...
  17. Plastino M, Fava A, Carmela C, De Bartolo M, Ermio C, Cristiano D, Ettore M, Abenavoli L, Bosco D. Insulin resistance increases risk of carpal tunnel syndrome: a case-control study. J Peripher Nerv Sys 2011; 16: 186-190. Go to original source... Go to PubMed...
  18. Pluijms W, Huygen F, Cheng J, Mekhail N, van Kleef M, van Zundert J, van Dongen R. 18. Painful diabetic polyneuropathy. Pain Pract 2011; 11: 191-198. Go to original source... Go to PubMed...
  19. Sharma KR, Cross J, Farronay O, Ram AD, Shebert RT, Bradley WG. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002; 59: 758-765. Go to original source... Go to PubMed...
  20. Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJM. on behalf of the Toronto expert panel on diabetic neuropathy. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Reviews 2011; 27: 629-638. Go to original source... Go to PubMed...
  21. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Reviews 2012; 28(Suppl 1): 8-14. Go to original source... Go to PubMed...
  22. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 2008; 9: 660-674. Go to original source... Go to PubMed...
  23. Vinik A, Mehrabyan A, Colen L, Boulton A. Focal entrapment neuropathies in diabetes. Diabetes Care 2004; 27: 1783-1788. Go to original source... Go to PubMed...
  24. Viswanathan V, Snehalatha C, Seena R, Ramachandran A. Early recognition of diabetic neuropathy: evaluation of a simple procedure using thermal perception. Postgrad Med J 2002; 78; 541-542. Go to original source... Go to PubMed...
  25. Wu Z, Mata M, Fink DJ. Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. Mol Ther 2011; 19: 310-317. Go to original source... Go to PubMed...
  26. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Invest 2011; 2: 18-32. Go to original source... Go to PubMed...
  27. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain. How far have we come? Diabetes Care 2008; 31(Suppl 2): S255-S261.
  28. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance. The MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009; 10: 393-400. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.